Compumedics (ASX:CMP) 6-Month Share Buyback Ratio: -3.92% (As of Dec. 2025 )


ASX:CMP Compumedics Ltd ASX:CMP
62 GF Score
Price A$0.27
GF Value A$0.32
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Compumedics 6-Month Share Buyback Ratio?

Compumedics ASX:CMP 62 6-Month Share Buyback Ratio is -3.92 as of Dec. 2025. GuruFocus rates ASX:CMP with a GF Score™ of 62/100 and a GF Value™ of A$0.32 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Compumedics's current 6-Month Share Buyback Ratio was -3.92%.

Compumedics  (ASX:CMP) 6-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Compumedics 6-Month Share Buyback Ratio Related Terms

ASX:CMP vs ABT, SYK, MDT: 6-Month Share Buyback Ratio Comparison

For the Medical Devices subindustry, Compumedics's 6-Month Share Buyback Ratio, along with its competitors' market caps and 6-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Compumedics 6-Month Share Buyback Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's 6-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Compumedics's 6-Month Share Buyback Ratio falls into.


ASX:CMP
62GF Score
Compumedics Ltd ASX:CMP
6-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compumedics 6-Month Share Buyback Ratio Calculation

Compumedics's 6-Month Share Buyback Ratio for the quarter that ended in Dec. 2025 is calculated as

6-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Jun. 2025 ) - Shares Outstanding (EOP) (Dec. 2025 )) / Shares Outstanding (EOP) (Jun. 2025 )
=(192.218 - 199.762) / 192.218
=-3.92%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 6-Month Share Buyback Ratio of -3.92 mean?
Compumedics (ASX:CMP) has a 6-Month Share Buyback Ratio of -3.92 as of Dec. 2025. The 6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. View historical data for Compumedics and its competitors.
Is Compumedics' 6-Month Share Buyback Ratio too high?
Compumedics' current 6-Month Share Buyback Ratio is -3.92. Overall, Compumedics has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Compumedics' 6-Month Share Buyback Ratio compare to ABT and SYK?
Compumedics' 6-Month Share Buyback Ratio of -3.92 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Share Buyback Ratio for a Medical Devices & Instruments company?
A good 6-Month Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 6-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Share Buyback Ratio mean?
A high 6-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. View historical data for Compumedics and its competitors. Compumedics's current 6-Month Share Buyback Ratio is -3.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.32, compared to a current price of A$0.27 — trading 15.6% below its estimated fair value. The current 6-Month Share Buyback Ratio is -3.92. Compumedics' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Share Buyback Ratio calculated?
6-Month Share Buyback Ratio is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current 6-Month Share Buyback Ratio is -3.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Compumedics (ASX:CMP) Overvalued in 2026?

Based on GuruFocus' analysis, Compumedics stock appears to be undervalued. The current stock price of A$0.27 is trading 15.6% below its estimated GF Value™ of A$0.32. GuruFocus considers Compumedics to be Modestly Undervalued.

Key valuation signals for ASX:CMP:

  • 6-Month Share Buyback Ratio: -3.92
  • GF Value™: A$0.32 vs. price of A$0.27 (15.6% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Compumedics Business Description

Address 30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
62GF Score

Get the complete analysis for ASX:CMP

6-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.27
Price
A$0.32
GF Value